Proprietary Laboratory Analyses Codes
AMA CPT code subset that uniquely identifies a single proprietary clinical lab test (LDT or IVD) for pricing and tracking.
Definition
Proprietary Laboratory Analyses (PLA) codes are a subset of CPT Category I codes, introduced by the AMA in 2018, that assign a unique CPT code to a single proprietary clinical laboratory or molecular diagnostic test. Unlike generic molecular CPT codes (the 81xxx 'stack codes'), PLA codes give CMS, MACs, and commercial payers a clean way to set test-specific pricing on the Clinical Laboratory Fee Schedule (CLFS). PLA applications are reviewed quarterly by the AMA CPT Editorial Panel.What this means in practice
PLA codes are the dominant route for branded molecular diagnostics (oncology liquid biopsy, MRD assays, transplant rejection assays) to achieve test-specific reimbursement. Filing strategy and crosswalk positioning materially affect realized price.Examples
- A developer of a novel genetic test for a rare disease would apply for a PLA code to ensure it can be specifically identified and reimbursed by payers.
- A lab introducing a new liquid biopsy test for early cancer detection would seek a PLA code to establish a unique payment rate on the Clinical Laboratory Fee Schedule.
- When a transplant center adopts a new assay to monitor organ rejection, the lab offering that specific test may use a PLA code for its billing to Medicare and commercial insurers.
- •Filing for PLA without a defensible crosswalk strategy, gapfill is unpredictable.
- •Confusing PLA code issuance with payer coverage; coverage is a separate MAC/commercial payer decision.
Frequently asked questions
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsAMA-maintained codes that describe medical procedures and services.
Private contractors that process Medicare Part A/B and DME claims and issue Local Coverage Determinations within their jurisdictions.
A Medicare molecular diagnostics program, administered by Palmetto GBA and adopted by several Medicare Administrative Contractors, that technically assesses molecular tests and assigns Z-codes for claims processing and local coverage.
Law that revised Medicare pricing for clinical lab services.
More in Reimbursement
· Same categoryFederal program providing discounted drugs to safety-net providers.
The Medicare grouping system that determines hospital outpatient payment amounts under OPPS, analogous to MS-DRGs for inpatient.
Migration of procedures from hospitals to ambulatory surgery centers.
Financial model that estimates the total cost consequences of adopting a new technology to a payer's budget over a defined horizon.
Where this term appears across MedTech Terms.
Latest in MedTech
Sources
2 sourcesSources support the definition or relevant regulatory context, not necessarily every claim on this page. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.
Official citation replacements checked: . Medicare documents support Medicare coding, coverage or payment context, not every payer policy or CPT editorial procedure. Citation replacement does not change the full term review date.
- 1CMS, Clinical Laboratory Fee ScheduleTier 2 VerifiedCMScms.gov
- 242 CFR 414.507: Payment for clinical diagnostic laboratory testsTier 1 UncheckedeCFRecfr.gov
Inline markers like [1] jump to the matching reference above.